lorazepam and dextropropoxyphene

lorazepam has been researched along with dextropropoxyphene in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abernethy, DR; Greenblatt, DJ; Morse, DS; Shader, RI1
Hanks, GW; O'Neill, WM; Simpson, P; Wesnes, K; White, L1
Fallon, MT; Hanks, GW; Jenkins, E; O'Neill, WM; Simpson, P; Wesnes, K1
Goldman, RE; Zacny, JP1

Reviews

1 review(s) available for lorazepam and dextropropoxyphene

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

4 trial(s) available for lorazepam and dextropropoxyphene

ArticleYear
Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
    British journal of clinical pharmacology, 1985, Volume: 19, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Dextropropoxyphene; Diazepam; Drug Interactions; Female; Half-Life; Humans; Kinetics; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged

1985
The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects.
    European journal of clinical pharmacology, 1995, Volume: 48, Issue:6

    Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Arousal; Cognition; Cross-Over Studies; Dextropropoxyphene; Double-Blind Method; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory; Mental Recall; Middle Aged; Psychomotor Performance; Reaction Time

1995
The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.
    Pain, 2000, Volume: 85, Issue:1-2

    Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Arousal; Cognition; Cross-Over Studies; Dextropropoxyphene; Double-Blind Method; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory; Mental Recall; Morphine; Psychomotor Performance; Reaction Time; Time Factors

2000
Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers.
    Drug and alcohol dependence, 2004, Feb-07, Volume: 73, Issue:2

    Topics: Adult; Anticonvulsants; Cognition; Cross-Over Studies; Dextropropoxyphene; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lorazepam; Lysergic Acid Diethylamide; Male; Miosis; Morphine; Narcotics; Psychomotor Performance

2004

Other Studies

5 other study(ies) available for lorazepam and dextropropoxyphene

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010